Keygene N.V., Genome Diagnostics B.V. and University Medical Center Utrecht obtained SenterNovem grant for an Innovative Collaboration feasibility study. SenterNovem has awarded a grant to the tripartite collaboration aiming at a technology for fast, accurate and affordable HLA typing.

Genome Diagnostics B.V. is a spin off of the UMC Utrecht and aims to offer accurate and affordable diagnostic tools to facilitate donor/recipient matching, ultimately leading to higher success rates of bone-marrow, cord blood and stem cell transplantations. 

University Medical Center Utrecht is a leading institute on HLA research and diagnostics and is the reference center for Sequencing Based Typing HLA Typing strategies Keygene N.V. is an innovative research company that develops and applies molecular genetics in plant breeding.

Keygene works for leading plant breeding companies, animal breeders, universities, hospitals and the fermentation and food industry. Research is performed on the Breeding by DesignTM concept and is carried out by using the powerful DNA fingerprinting technology AFLP®, CRoPSTM for high throughput SNP identification the multiplexed SNP detection technology SNPWaveTM and the gene expression technology cDNA AFLP® for gene and promoter identification. Keygene's aim is to support companies and institutes that carry out fundamental or applied genetic/genomic research or that seek to enhance the quality of their product through the improvement of the genetic material used in the production process.

AFLP® is a registered trademark of Keygene N.V. The AFLP® technology is covered by patents and patent applications of Keygene N.V. SNPWave™, Breeding by Design™ and CRoPS™ are trademarks of Keygene N.V. SBTengine® is a registered trademark of Genome Diagnostics